Ensysce Biosciences, Inc. (ENSC)
USD 6.07
(-4.56%)
USD 6.07
(-4.56%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -10.77 Million | -17.88 Million | -8.24 Million | -1.24 Million | 10.99 Million | -1.23 Million |
| Net Income | -10.62 Million | -24.2 Million | -29.14 Million | -160.87 Thousand | 365.95 Thousand | -1.34 Million |
| Depreciation & Amortization | 326.15 Thousand | - | 151.00 | 201.00 | 201.00 | - |
| Deferred income taxes | 1.23 Million | - | 14.59 Million | -2.44 Million | -1764.00 | 1764.00 |
| Stock-based compensation | 879.16 Thousand | 1.07 Million | 121.76 Thousand | 178.67 Thousand | 6.03 Million | - |
| Change in working capital | -947.07 Thousand | 5.48 Million | -1.3 Million | 185.1 Thousand | 2.46 Million | 273.12 Thousand |
| Other non-cash items | -1.64 Million | -233.41 Thousand | 7.48 Million | 997.45 Thousand | 8.16 Million | -317.21 Thousand |
| Investing Cash Flow | - | 4500.00 | - | 183.4 Million | -566.28 Thousand | 838.58 Thousand |
| Investments in PPE | 2.00 | - | - | - | - | - |
| Acquisitions | - | 4500.00 | - | - | - | - |
| Investment purchases | - | - | - | - | -566.28 Thousand | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | 4500.00 | - | 183.4 Million | 11.85 Million | 838.58 Thousand |
| Financing Cash Flow | 8.75 Million | 8.76 Million | 20.31 Million | 1.1 Million | -11.02 Million | -32 Thousand |
| Debt repayment | -605.42 Thousand | -1.4 Million | -467.77 Thousand | -1.1 Million | -566.26 Thousand | - |
| Dividends payments | -12.93 Thousand | -913.2 Thousand | -803.14 Billion | - | - | - |
| Common Stock Repurchased | - | - | 803.14 Billion | - | -11.58 Million | - |
| Common Stock Issuance | 9.05 Million | 3.78 Million | 6.62 Million | - | -8640.00 | -32 Thousand |
| Other Financing Activities | -899.54 Thousand | 7.3 Million | 14.15 Million | 2.2 Million | 100 Thousand | -32 Thousand |
| Accounts receivables | 179.26 Thousand | 164.9 Thousand | -441.72 Thousand | 173.55 Thousand | -173.55 Thousand | -170.53 Thousand |
| Accounts payables | -1.23 Million | 2.64 Million | -1.42 Million | 1.18 Million | 2.34 Million | 317.28 Thousand |
| Inventory | -1.12 Million | -164.9 Thousand | 441.72 Thousand | -173.55 Thousand | -2.16 Million | - |
| Other working capital | 1.23 Million | 2.83 Million | 120 Thousand | -998.71 Thousand | 2.46 Million | 126.38 Thousand |
| Cash at beginning of period | 3.14 Million | 12.26 Million | 194.21 Thousand | 341.53 Thousand | 1.65 Million | 2.09 Million |
| Cash at end of period | 1.12 Million | 3.14 Million | 12.26 Million | 194.21 Thousand | 1.06 Million | 1.65 Million |
| Capital Expenditure | 2.00 | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | -183.4 Million | 938.78 Thousand | - |
| Net cash flow / Change in cash | -2.02 Million | -9.11 Million | 12.07 Million | -147.32 Thousand | -597.24 Thousand | -431.67 Thousand |
| Free Cash Flow | -10.77 Million | -17.88 Million | -8.24 Million | -1.24 Million | 10.99 Million | -1.23 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.96 Million | -3.11 Million | -3.5 Million | -10.62 Million | -2.69 Million | -2.23 Million |
| Depreciation & Amortization | 25.73 Thousand | 1.17 Million | 326.15 Thousand | 326.15 Thousand | - | - |
| Deferred income taxes | - | - | -476.71 Thousand | 1.23 Million | - | - |
| Stock-based compensation | 26.54 Thousand | 33.2 Thousand | 628.93 Thousand | 879.16 Thousand | 55.67 Thousand | 77.41 Thousand |
| Change in working capital | -388.39 Thousand | -1.51 Million | 741.99 Thousand | -947.07 Thousand | 382.1 Thousand | -902.99 Thousand |
| Other non-cash items | 674.04 Thousand | 2.51 Million | 482.11 Thousand | -1.64 Million | -9619.00 | -43.66 Thousand |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | -51.22 Thousand | 5.68 Million | 1.46 Million | 8.75 Million | -102.45 Thousand | 5.52 Million |
| Debt repayment | -51.22 Thousand | -485.19 Thousand | -1.6 Million | -605.42 Thousand | -102.45 Thousand | -584.85 Thousand |
| Dividends payments | - | -290.00 | -4628.00 | -12.93 Thousand | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 6.79 Million | -9.05 Million | 9.05 Million | - | 6.36 Million |
| Other Financing Activities | -51.22 Thousand | -619.17 Thousand | -144.53 Thousand | -899.54 Thousand | -102.45 Thousand | -253.83 Thousand |
| Accounts receivables | -127.99 Thousand | 1337.00 | -169.24 Thousand | 179.26 Thousand | -160.00 | 181.73 Thousand |
| Accounts payables | -499.74 Thousand | -1.29 Million | 793.08 Thousand | -1.23 Million | -358.21 Thousand | -323.53 Thousand |
| Inventory | - | - | 1.33 Million | -1.12 Million | 160.00 | -181.73 Thousand |
| Other working capital | 239.35 Thousand | -220.52 Thousand | -1.21 Million | 1.23 Million | 740.31 Thousand | -579.45 Thousand |
| Cash at beginning of period | 3.4 Million | 1.12 Million | 1.46 Million | 3.14 Million | 3.82 Million | 1.41 Million |
| Cash at end of period | 1.04 Million | 3.4 Million | 1.12 Million | 1.12 Million | 1.46 Million | 3.82 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -2.36 Million | 2.28 Million | -340.77 Thousand | -2.02 Million | -2.36 Million | 2.41 Million |
| Free Cash Flow | -2.3 Million | -3.4 Million | -1.8 Million | -10.77 Million | -2.26 Million | -3.1 Million |
6625
2993
IHR
AMG
CYYHF
SGMA